INS and neoplasm: TZDs promote insulin sensitivity by activating peroxisome proliferator-activated receptor gamma (PPAR-γ) which has been found to suppress tumor growth in various types of tumor cells by the downregulation of proliferation and insulin resistance and induction of apoptosis [1,204,205].